Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation, 70190-70194 [2020-24466]
Download as PDF
<![CDATA[
70190
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: October 29, 2020.
Lisa Barton,
Secretary to the Commission.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
January 4, 2021.
DATES:
[FR Doc. 2020–24390 Filed 11–3–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–741]
Bulk Manufacturer of Controlled
Substances Application: Navinta LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 25, 2020,
Navinta LLC 1499 Lower Ferry Road,
Ewing, New Jersey 08618–1414, applied
to be registered as an bulk manufacturer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Navinta LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
SUMMARY:
Controlled substance
Drug code
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture active pharmaceutical
ingredients (API) quantities of the listed
controlled substances for validation
purposes and the Food and Drug
Administration’s approval. No other
activity for these drug codes is
authorized for this registration.
DEPARTMENT OF JUSTICE
William T. McDermott,
Assistant Administrator.
AGENCY:
Drug Enforcement Administration
[Docket No. DEA–717]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
[FR Doc. 2020–24465 Filed 11–3–20; 8:45 am]
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
BILLING CODE 4410–09–P
SUMMARY:
Cerilliant Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 6, 2020,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, applied to be registered as
an bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ...............................................................................................................................
Naphyrone .......................................................................................................................................................................
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
II
II
II
II
II
comments on or objections to the
issuance of the proposed registration on
or before January 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
January 4, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
Controlled substance
2 All contract personnel will sign appropriate
nondisclosure agreements.
8333
9210
9220
9739
9801
Schedule
E:\FR\FM\04NON1.SGM
04NON1
1233
1235
1237
1238
1246
1248
1249
1258
Schedule
I
I
I
I
I
I
I
I
70191
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
N-Ethylamphetamine .......................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Fenethylline .....................................................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ...................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) .................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................
FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ...............................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ......................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................
FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate).
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .................................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...............
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..............................................
5F–ADB, 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................
5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .........................
5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..............................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........
FUB–AKB48, FUB–APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) ...................................................................................................
5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ....................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ...............
4–CN–CUML–BUTINACA, 4–cyano–CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–
78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) ....................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ......................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) .......................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..........................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ........................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) .......................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl1-(5-fluoropentyl)-1H-indole-3-carboxylate ...........................................................
PB–22 (Quinolin-8-yl1-pentyl-1H-indole-3-carboxylate) ..................................................................................................
5F–PB–22 (Quinolin-8-yl1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................
4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) .....................................................................................................
N-Ethylhexedrone ............................................................................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
CP–47, 497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ...............................................................
CP–47, 497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .........................................
Lysergic acid diethylamide ..............................................................................................................................................
2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ...............................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Parahexyl .........................................................................................................................................................................
Mescaline .........................................................................................................................................................................
2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) .............................................................................................
3,4,5-Trimethoxyamphetamine ........................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) .......................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\04NON1.SGM
04NON1
Schedule
1475
1480
1503
1585
1590
2010
2565
6250
7008
7010
7011
7012
7014
7019
7020
7021
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
I
I
I
I
I
I
I
I
I
I
I
7044
7047
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7297
7298
7315
7348
7360
7370
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
70192
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
4-Methoxyamphetamine ..................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
4′-Chloro-alpha-pyrrolidinovalerophenone .......................................................................................................................
MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ...........................................................................................................
N-Ethyl-1-phenylcyclohexylamine ....................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .....................................................................................................
2C–D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine) ...................................................................................................
2C–E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) ......................................................................................................
2C–H 2-(2,5-Dimethoxyphenyl)ethanamine) ...................................................................................................................
2C–I 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine) ..........................................................................................................
2C–C 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine) .....................................................................................................
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine) .....................................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine) ..............................................................................................
2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl)ethanamine) .....................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) .....................................................
25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) .....................................................
25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine) ..........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .....................................................
a–PHP, alpha-Pyrrolidinohexanophenone ......................................................................................................................
alpha-pyrrolidinopentiophenone (a–PVP) .......................................................................................................................
alpha-pyrrolidinobutiophenone (a–PBP) .........................................................................................................................
Ethylone ...........................................................................................................................................................................
PV8, alpha-Pyrrolidinoheptaphenone ..............................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) ....................................................................................................
Acetyldihydrocodeine .......................................................................................................................................................
Benzylmorphine ...............................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Desomorphine .................................................................................................................................................................
Codeine methylbromide ...................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Hydromorphinol ...............................................................................................................................................................
Methyldesorphine ............................................................................................................................................................
Methyldihydromorphine ...................................................................................................................................................
Morphine methylbromide .................................................................................................................................................
Morphine methylsulfonate ...............................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Normorphine ....................................................................................................................................................................
Pholcodine .......................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..............................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..................................................................................................
Acetylmethadol ................................................................................................................................................................
Allylprodine ......................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ......................................................................................................
Alphameprodine ...............................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Betameprodine ................................................................................................................................................................
Betamethadol ...................................................................................................................................................................
Betaprodine .....................................................................................................................................................................
Isotonitazene ...................................................................................................................................................................
Dipipanone .......................................................................................................................................................................
Hydroxypethidine .............................................................................................................................................................
Noracymethadol ...............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Normethadone .................................................................................................................................................................
Trimeperidine ...................................................................................................................................................................
Phenomorphan ................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\04NON1.SGM
04NON1
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7548
7694
9051
9052
9053
9055
9070
9145
9200
9301
9302
9304
9305
9306
9307
9313
9314
9547
9551
9560
9601
9602
9603
9604
9605
9607
9608
9609
9611
9614
9622
9627
9633
9634
9635
9646
9647
9661
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
70193
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Tilidine .............................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide .......................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Butyryl Fentanyl ...............................................................................................................................................................
Para-fluorobutyryl fentanyl ...............................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .........................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .........................................................................................
Para-chloroisobutyryl fentanyl .........................................................................................................................................
Isobutyryl fentanyl ............................................................................................................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
Beta-hydroxythiofentanyl .................................................................................................................................................
Para-methoxybutyryl fentanyl ..........................................................................................................................................
Ocfentanil .........................................................................................................................................................................
Valeryl fentanyl ................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..........................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Cyclopentyl fentanyl ........................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
8Amphetamine .................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
1-Phenylcyclohexylamine ................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .....................................................................................................................
Norfentanyl ......................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Isomethadone ..................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate–A ..............................................................................................................................................
Meperidine intermediate–B ..............................................................................................................................................
Meperidine intermediate–C .............................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Thiafentanil ......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
E:\FR\FM\04NON1.SGM
04NON1
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8366
8603
9010
9041
9050
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9273
9300
9333
9648
9652
9668
9729
9732
9737
9739
9740
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
70194
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
Controlled substance
Drug code
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture small quantities of the
listed controlled substances to make
reference standards which will be
distributed to its customers. No other
activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–24466 Filed 11–3–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act, the Comprehensive Environmental
Response, Compensation, and Liability
Act, and the Emergency Planning and
Community Right-To-Know Act
On October 28, 2020, the Department
of Justice filed a complaint and lodged
a proposed Consent Decree with the
United States District Court for the
District of Arizona (‘‘Court’’) in the
matter of United States of America v.
Apache Nitrogen Products, Inc., Civil
Action No. 4:20–cv–00463–BGM (D.
Ariz.).
The proposed Consent Decree
resolves certain claims brought under
Sections 112(r)(1) and 112(r)(7) of the
Clean Air Act (‘‘CAA’’), 42 U.S.C.
7412(r)(1), (r)(7); Section 103 of the
Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’), 42 U.S.C. 9603; and
Section 304 of the Emergency Planning
and Community Right-to-Know Act
(‘‘EPCRA’’), 42 U.S.C. 11004, at the
chemical manufacturing facility that
Apache Nitrogen Products, Inc.
(‘‘Apache Nitrogen’’) owns and operates
in Cochise County, Arizona. The claims
alleged in the complaint and resolved in
the proposed Consent Decree concern
Apache Nitrogen’s prevention and
mitigation of accidental chemical
releases. The Consent Decree requires
Apache Nitrogen to perform safety
improvements at its Cochise County,
Arizona facility, including making
improvements to Apache Nitrogen’s
preventive maintenance tracking
system, conducting an audit of its
process safety culture, and upgrading its
emergency response plan to include
installation of an anhydrous ammonia
monitoring system and enhanced public
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
notification. The Consent Decree also
documents that the company has
replaced or upgraded equipment to
improve accident prevention. The
Consent Decree requires Apache
Nitrogen to pay a civil penalty of
$1,500,000 to the United States.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States of America v. Apache
Nitrogen Products, Inc., D.J. Ref. No. 90–
5–2–1–10736/1. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.usdoj.gov/enrd/consent-decrees.
We will provide a paper copy of the
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $15.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Lori Jonas,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2020–24482 Filed 11–3–20; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On October 29, 2020, the Department
of Justice lodged a proposed Consent
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
9743
9780
9801
Schedule
II
II
II
Decree with the United States District
Court for the District of Colorado in the
lawsuit entitled United States of
America, the State of Colorado, the
Lower Arkansas Valley Water
Conservancy District, and the Board of
County Commissioners in the County of
Pueblo v. the City of Colorado Springs,
Colorado, Civil Action No. 1:16–cv–
02745–JLK.
The lawsuit seeks injunctive relief
and civil penalties for violations of the
Clean Water Act, 33 U.S.C. 1319(b) and
(d), based on the City’s violations of the
terms and conditions of its National
Pollutant Discharge Elimination System
(‘‘NPDES’’) permit issued by the State of
Colorado under Section 402(b) of the
Clean Water Act, 33 U.S.C. 1342(b), for
discharges of stormwater from the City’s
municipal separate storm sewer system,
as well as for violations of the Colorado
Water Quality Control Act, §§ 25–8–101
et seq. C.R.S.
The proposed Consent Decree
resolves all litigation in this action. The
proposed Consent Decree requires the
City of Colorado Springs to implement
city-wide injunctive relief to comply
with its NPDES permit, perform $11
million of mitigation to offset the
environmental harm caused by its
alleged violations, and pay the United
States a $1 million civil penalty. In
addition, in lieu of receiving a civil
penalty payment, the State of Colorado
agrees that the City shall satisfy the
State civil penalty through performance
of a State approved supplemental
environmental project valued at $1
million, to be performed by Intervenor
Plaintiff the Lower Arkansas Valley
Water Conservancy District.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States, et al. v. the City of
Colorado Springs, Colorado, Civil
Action No. 1:16–cv–02745–JLK, DOJ
number 90–5–1–1–11293. All comments
must be submitted no later than 30 days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Pages 70190-70194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24466]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-717]
Bulk Manufacturer of Controlled Substances Application:
Cerilliant Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before January 4, 2021.
Such persons may also file a written request for a hearing on the
application on or before January 4, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 6, 2020, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered
as an bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC). 1233 I
Cathinone.......................... 1235 I
Methcathinone...................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC). 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC).. 1249 I
Naphyrone.......................... 1258 I
[[Page 70191]]
N-Ethylamphetamine................. 1475 I
N,N-Dimethylamphetamine............ 1480 I
Fenethylline....................... 1503 I
Aminorex........................... 1585 I
4-Methylaminorex (cis isomer)...... 1590 I
Gamma Hydroxybutyric Acid.......... 2010 I
Methaqualone....................... 2565 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl)indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl)indole).
ADB-FUBINACA (N-(1-amino-3,3- 7010 I
dimethyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H- 7014 I
indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA 7021 I
(2-(1-(4-fluorobenzyl)-1Hindazole-
3-carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone).
5F-AB-PINACA (N-(1-amino-3-methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluropentyl)-
1H-indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5- 7033 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3-methylbutanoate).
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1- 7034 I
(5-fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl- 7035 I
1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5- 7036 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5- 7041 I
fluoropentyl)-1H-indole-3-
carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2- 7042 I
(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-
dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-
1-(4-fluorobenzyl)-1H-indazole-3-
carboximide).
APINACA and AKB48 (N-(1-Adamantyl)- 7048 I
1-pentyl-1H-indazole-3-
carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan- 7049 I
1-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl)indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5- 7083 I
fluoropentyl)-N-(2-phenylpropan-2-
yl)-1H-indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)- 7085 I
N-(2-phenylpropan-2-yl)-1H-
pyrrolo[2,3-b]pyridine-3-
carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-
4CN-BINACA, SGT-78 (1-(4-
cyanobutyl)-N-(2-phenylpropan-2-
yl)-1H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-
benzoyl]indole).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl)indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]- 7200 I
3-(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl)indole).
NM2201, CBL2201 (Naphthalen-1-yl1- 7221 I
(5-fluoropentyl)-1H-indole-3-
carboxylate.
PB-22 (Quinolin-8-yl1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone................... 7246 I
Alpha-ethyltryptamine.............. 7249 I
CP-47, 497 (5-(1,1-Dimethylheptyl)- 7297 I
2-[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47, 497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide......... 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Parahexyl.......................... 7374 I
Mescaline.......................... 7381 I
2C-T-2 (2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl)ethanamine).
3,4,5-Trimethoxyamphetamine........ 7390 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine.. 7395 I
2,5-Dimethoxyamphetamine........... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl)indole).
2,5-Dimethoxy-4-ethylamphetamine... 7399 I
3,4-Methylenedioxyamphetamine...... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine.. 7405 I
[[Page 70192]]
4-Methoxyamphetamine............... 7411 I
5-Methoxy-N-N-dimethyltryptamine... 7431 I
Alpha-methyltryptamine............. 7432 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocybin......................... 7437 I
Psilocyn........................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine 7439 I
4'-Chloro-alpha- 7443 I
pyrrolidinovalerophenone.
MPHP, 4'-Methyl-alpha- 7446 I
pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine.... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine.. 7458 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine................. 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4- 7508 I
methylphenyl)ethanamine).
2C-E (2-(2,5-Dimethoxy-4- 7509 I
ethylphenyl)ethanamine).
2C-H 2-(2,5- 7517 I
Dimethoxyphenyl)ethanamine).
2C-I 2-(4-iodo-2,5- 7518 I
dimethoxyphenyl)ethanamine).
2C-C 2-(4-Chloro-2,5- 7519 I
dimethoxyphenyl)ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl)ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl)ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl)ethanamine).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
25B-NBOMe (2-(4-bromo-2,5- 7536 I
dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine).
25C-NBOMe (2-(4-chloro-2,5- 7537 I
dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine).
25I-NBOMe (2-(4-iodo-2,5- 7538 I
dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone........................... 7541 I
Pentylone.......................... 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-
pentan-1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
Ethylone........................... 7547 I
PV8, alpha-Pyrrolidinoheptaphenone. 7548 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl)indole).
Acetyldihydrocodeine............... 9051 I
Benzylmorphine..................... 9052 I
Codeine-N-oxide.................... 9053 I
Desomorphine....................... 9055 I
Codeine methylbromide.............. 9070 I
Dihydromorphine.................... 9145 I
Heroin............................. 9200 I
Hydromorphinol..................... 9301 I
Methyldesorphine................... 9302 I
Methyldihydromorphine.............. 9304 I
Morphine methylbromide............. 9305 I
Morphine methylsulfonate........... 9306 I
Morphine-N-oxide................... 9307 I
Normorphine........................ 9313 I
Pholcodine......................... 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]ben
zamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol..................... 9601 I
Allylprodine....................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine..................... 9604 I
Alphamethadol...................... 9605 I
Betacetylmethadol.................. 9607 I
Betameprodine...................... 9608 I
Betamethadol....................... 9609 I
Betaprodine........................ 9611 I
Isotonitazene...................... 9614 I
Dipipanone......................... 9622 I
Hydroxypethidine................... 9627 I
Noracymethadol..................... 9633 I
Norlevorphanol..................... 9634 I
Normethadone....................... 9635 I
Trimeperidine...................... 9646 I
Phenomorphan....................... 9647 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
[[Page 70193]]
Tilidine........................... 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl................ 9812 I
3-Methylfentanyl................... 9813 I
Alpha-methylfentanyl............... 9814 I
Acetyl-alpha-methylfentanyl........ 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-
yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl................... 9822 I
Para-fluorobutyryl fentanyl........ 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4- 9825 I
yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl..... 9826 I
Isobutyryl fentanyl................ 9827 I
Beta-hydroxyfentanyl............... 9830 I
Beta-hydroxy-3-methylfentanyl...... 9831 I
Alpha-methylthiofentanyl........... 9832 I
3-Methylthiofentanyl............... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl....................... 9835 I
Beta-hydroxythiofentanyl........... 9836 I
Para-methoxybutyryl fentanyl....... 9837 I
Ocfentanil......................... 9838 I
Valeryl fentanyl................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-
carboxamide.
Cyclopropyl Fentanyl............... 9845 I
Cyclopentyl fentanyl............... 9847 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11(h).
8Amphetamine....................... 1100 II
Methamphetamine.................... 1105 II
Lisdexamfetamine................... 1205 II
Phenmetrazine...................... 1631 II
Methylphenidate.................... 1724 II
Amobarbital........................ 2125 II
Pentobarbital...................... 2270 II
Secobarbital....................... 2315 II
Glutethimide....................... 2550 II
Nabilone........................... 7379 II
1-Phenylcyclohexylamine............ 7460 II
Phencyclidine...................... 7471 II
ANPP (4-Anilino-N-phenethyl-4- 8333 II
piperidine).
Norfentanyl........................ 8366 II
1-Piperidinocyclohexanecarbonitrile 8603 II
Alphaprodine....................... 9010 II
Cocaine............................ 9041 II
Codeine............................ 9050 II
Dihydrocodeine..................... 9120 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Diphenoxylate...................... 9170 II
Ecgonine........................... 9180 II
Ethylmorphine...................... 9190 II
Hydrocodone........................ 9193 II
Levomethorphan..................... 9210 II
Levorphanol........................ 9220 II
Isomethadone....................... 9226 II
Meperidine......................... 9230 II
Meperidine intermediate-A.......... 9232 II
Meperidine intermediate-B.......... 9233 II
Meperidine intermediate-C.......... 9234 II
Metazocine......................... 9240 II
Methadone.......................... 9250 II
Methadone intermediate............. 9254 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................... 9300 II
Thebaine........................... 9333 II
Levo-alphacetylmethadol............ 9648 II
Oxymorphone........................ 9652 II
Noroxymorphone..................... 9668 II
Thiafentanil....................... 9729 II
Racemethorphan..................... 9732 II
Alfentanil......................... 9737 II
Remifentanil....................... 9739 II
Sufentanil......................... 9740 II
[[Page 70194]]
Carfentanil........................ 9743 II
Tapentadol......................... 9780 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture small quantities of the
listed controlled substances to make reference standards which will be
distributed to its customers. No other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-24466 Filed 11-3-20; 8:45 am]
BILLING CODE 4410-09-P
